Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma

Zheng, Yan , Wang, Zhao , Gu, Wenyi , Ding, Xu , Dong, Yibo , Zhang, Wei , Zhang, Wei , Song, Xiaomeng , Wu, Yunong and Zhong, Yi (2017) Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma. Cell Proliferation, . doi:10.1111/cpr.12424


Author Zheng, Yan
Wang, Zhao
Gu, Wenyi
Ding, Xu
Dong, Yibo
Zhang, Wei
Zhang, Wei
Song, Xiaomeng
Wu, Yunong
Zhong, Yi
Title Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma
Journal name Cell Proliferation
Publication date 2017-12-12
Year available 2017
Sub-type Article (original research)
DOI 10.1111/cpr.12424
Open Access Status Not yet assessed
Total pages 11
Language eng
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: HERDC Pre-Audit
Australian Institute for Bioengineering and Nanotechnology Publications
 
Versions
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Thu, 04 Jan 2018, 16:53:07 EST by Dr Wenyi Gu on behalf of Aust Institute for Bioengineering & Nanotechnology